Cargando…

824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis

Detalles Bibliográficos
Autores principales: Marty, Francisco M., Perfect, John R., Cornely, Oliver A., Mullane, Kathleen M., Rahav, Galia, Lee, Misun, Ito, Masanori, Maher, Rochelle, Zeiher, Bernhardt, Ostrosky-Zeichner, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782119/
http://dx.doi.org/10.1093/ofid/ofu052.532
_version_ 1783295119428943872
author Marty, Francisco M.
Perfect, John R.
Cornely, Oliver A.
Mullane, Kathleen M.
Rahav, Galia
Lee, Misun
Ito, Masanori
Maher, Rochelle
Zeiher, Bernhardt
Ostrosky-Zeichner, Luis
author_facet Marty, Francisco M.
Perfect, John R.
Cornely, Oliver A.
Mullane, Kathleen M.
Rahav, Galia
Lee, Misun
Ito, Masanori
Maher, Rochelle
Zeiher, Bernhardt
Ostrosky-Zeichner, Luis
author_sort Marty, Francisco M.
collection PubMed
description
format Online
Article
Text
id pubmed-5782119
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-57821192018-03-01 824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis Marty, Francisco M. Perfect, John R. Cornely, Oliver A. Mullane, Kathleen M. Rahav, Galia Lee, Misun Ito, Masanori Maher, Rochelle Zeiher, Bernhardt Ostrosky-Zeichner, Luis Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5782119/ http://dx.doi.org/10.1093/ofid/ofu052.532 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America
spellingShingle IDWeek 2014 Abstracts
Marty, Francisco M.
Perfect, John R.
Cornely, Oliver A.
Mullane, Kathleen M.
Rahav, Galia
Lee, Misun
Ito, Masanori
Maher, Rochelle
Zeiher, Bernhardt
Ostrosky-Zeichner, Luis
824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
title 824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
title_full 824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
title_fullStr 824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
title_full_unstemmed 824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
title_short 824 An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis
title_sort 824 an open-label phase 3 study of isavuconazole (vital): focus on mucormycosis
topic IDWeek 2014 Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782119/
http://dx.doi.org/10.1093/ofid/ofu052.532
work_keys_str_mv AT martyfranciscom 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT perfectjohnr 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT cornelyolivera 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT mullanekathleenm 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT rahavgalia 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT leemisun 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT itomasanori 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT maherrochelle 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT zeiherbernhardt 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis
AT ostroskyzeichnerluis 824anopenlabelphase3studyofisavuconazolevitalfocusonmucormycosis